Focus on Osteosclerotic Progression in Primary Myelofibrosis

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by hematopoietic stem-cell-derived clonal proliferation, leading to bone marrow (BM) fibrosis. Hematopoiesis alterations are closely associated with modifications of the BM microenvironment, characterized by defective interac...

Full description

Bibliographic Details
Main Authors: Mariarita Spampinato, Cesarina Giallongo, Alessandra Romano, Lucia Longhitano, Enrico La Spina, Roberto Avola, Grazia Scandura, Ilaria Dulcamare, Vincenzo Bramanti, Michelino Di Rosa, Nunzio Vicario, Rosalba Parenti, Giovanni Li Volti, Daniele Tibullo, Giuseppe A. Palumbo
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/1/122
_version_ 1797409989313167360
author Mariarita Spampinato
Cesarina Giallongo
Alessandra Romano
Lucia Longhitano
Enrico La Spina
Roberto Avola
Grazia Scandura
Ilaria Dulcamare
Vincenzo Bramanti
Michelino Di Rosa
Nunzio Vicario
Rosalba Parenti
Giovanni Li Volti
Daniele Tibullo
Giuseppe A. Palumbo
author_facet Mariarita Spampinato
Cesarina Giallongo
Alessandra Romano
Lucia Longhitano
Enrico La Spina
Roberto Avola
Grazia Scandura
Ilaria Dulcamare
Vincenzo Bramanti
Michelino Di Rosa
Nunzio Vicario
Rosalba Parenti
Giovanni Li Volti
Daniele Tibullo
Giuseppe A. Palumbo
author_sort Mariarita Spampinato
collection DOAJ
description Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by hematopoietic stem-cell-derived clonal proliferation, leading to bone marrow (BM) fibrosis. Hematopoiesis alterations are closely associated with modifications of the BM microenvironment, characterized by defective interactions between vascular and endosteal niches. As such, neoangiogenesis, megakaryocytes hyperplasia and extensive bone marrow fibrosis, followed by osteosclerosis and bone damage, are the most relevant consequences of PMF. Moreover, bone tissue deposition, together with progressive fibrosis, represents crucial mechanisms of disabilities in patients. Although the underlying mechanisms of bone damage observed in PMF are still unclear, the involvement of cytokines, growth factors and bone marrow microenvironment resident cells have been linked to disease progression. Herein, we focused on the role of megakaryocytes and their alterations, associated with cytokines and chemokines release, in modulating functions of most of the bone marrow cell populations and in creating a complex network where impaired signaling strongly contributes to progression and disabilities.
first_indexed 2024-03-09T04:23:27Z
format Article
id doaj.art-f5bfe06bcda94a9795bf844533391336
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-09T04:23:27Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-f5bfe06bcda94a9795bf8445333913362023-12-03T13:44:42ZengMDPI AGBiomolecules2218-273X2021-01-0111112210.3390/biom11010122Focus on Osteosclerotic Progression in Primary MyelofibrosisMariarita Spampinato0Cesarina Giallongo1Alessandra Romano2Lucia Longhitano3Enrico La Spina4Roberto Avola5Grazia Scandura6Ilaria Dulcamare7Vincenzo Bramanti8Michelino Di Rosa9Nunzio Vicario10Rosalba Parenti11Giovanni Li Volti12Daniele Tibullo13Giuseppe A. Palumbo14Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalyDepartment of Medical and Surgical Sciences and Advanced Technologies “G.F. Ingrassia”, University of Catania, 95123 Catania, ItalyDepartment of General Surgery and Medical-Surgical Specialties, Division of Hematology, A.O.U. “Policlinico-Vittorio Emanuele”, University of Catania, 95123 Catania, ItalySection of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalyDepartment of General Surgery and Medical-Surgical Specialties, Division of Hematology, A.O.U. “Policlinico-Vittorio Emanuele”, University of Catania, 95123 Catania, ItalySection of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalyDepartment of General Surgery and Medical-Surgical Specialties, Division of Hematology, A.O.U. “Policlinico-Vittorio Emanuele”, University of Catania, 95123 Catania, ItalyDepartment of General Surgery and Medical-Surgical Specialties, Division of Hematology, A.O.U. “Policlinico-Vittorio Emanuele”, University of Catania, 95123 Catania, ItalyDivision of Clinical Pathology, “Giovanni Paolo II” Hospital–A.S.P. Ragusa, 97100 Ragusa, ItalySection of Human Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalySection of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalySection of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalySection of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalySection of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalyDepartment of Medical and Surgical Sciences and Advanced Technologies “G.F. Ingrassia”, University of Catania, 95123 Catania, ItalyPrimary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by hematopoietic stem-cell-derived clonal proliferation, leading to bone marrow (BM) fibrosis. Hematopoiesis alterations are closely associated with modifications of the BM microenvironment, characterized by defective interactions between vascular and endosteal niches. As such, neoangiogenesis, megakaryocytes hyperplasia and extensive bone marrow fibrosis, followed by osteosclerosis and bone damage, are the most relevant consequences of PMF. Moreover, bone tissue deposition, together with progressive fibrosis, represents crucial mechanisms of disabilities in patients. Although the underlying mechanisms of bone damage observed in PMF are still unclear, the involvement of cytokines, growth factors and bone marrow microenvironment resident cells have been linked to disease progression. Herein, we focused on the role of megakaryocytes and their alterations, associated with cytokines and chemokines release, in modulating functions of most of the bone marrow cell populations and in creating a complex network where impaired signaling strongly contributes to progression and disabilities.https://www.mdpi.com/2218-273X/11/1/122primary myelofibrosisbonemyeloproliferative neoplasmbone marrowfibrosis
spellingShingle Mariarita Spampinato
Cesarina Giallongo
Alessandra Romano
Lucia Longhitano
Enrico La Spina
Roberto Avola
Grazia Scandura
Ilaria Dulcamare
Vincenzo Bramanti
Michelino Di Rosa
Nunzio Vicario
Rosalba Parenti
Giovanni Li Volti
Daniele Tibullo
Giuseppe A. Palumbo
Focus on Osteosclerotic Progression in Primary Myelofibrosis
Biomolecules
primary myelofibrosis
bone
myeloproliferative neoplasm
bone marrow
fibrosis
title Focus on Osteosclerotic Progression in Primary Myelofibrosis
title_full Focus on Osteosclerotic Progression in Primary Myelofibrosis
title_fullStr Focus on Osteosclerotic Progression in Primary Myelofibrosis
title_full_unstemmed Focus on Osteosclerotic Progression in Primary Myelofibrosis
title_short Focus on Osteosclerotic Progression in Primary Myelofibrosis
title_sort focus on osteosclerotic progression in primary myelofibrosis
topic primary myelofibrosis
bone
myeloproliferative neoplasm
bone marrow
fibrosis
url https://www.mdpi.com/2218-273X/11/1/122
work_keys_str_mv AT mariaritaspampinato focusonosteoscleroticprogressioninprimarymyelofibrosis
AT cesarinagiallongo focusonosteoscleroticprogressioninprimarymyelofibrosis
AT alessandraromano focusonosteoscleroticprogressioninprimarymyelofibrosis
AT lucialonghitano focusonosteoscleroticprogressioninprimarymyelofibrosis
AT enricolaspina focusonosteoscleroticprogressioninprimarymyelofibrosis
AT robertoavola focusonosteoscleroticprogressioninprimarymyelofibrosis
AT graziascandura focusonosteoscleroticprogressioninprimarymyelofibrosis
AT ilariadulcamare focusonosteoscleroticprogressioninprimarymyelofibrosis
AT vincenzobramanti focusonosteoscleroticprogressioninprimarymyelofibrosis
AT michelinodirosa focusonosteoscleroticprogressioninprimarymyelofibrosis
AT nunziovicario focusonosteoscleroticprogressioninprimarymyelofibrosis
AT rosalbaparenti focusonosteoscleroticprogressioninprimarymyelofibrosis
AT giovannilivolti focusonosteoscleroticprogressioninprimarymyelofibrosis
AT danieletibullo focusonosteoscleroticprogressioninprimarymyelofibrosis
AT giuseppeapalumbo focusonosteoscleroticprogressioninprimarymyelofibrosis